跳至主要内容
临床试验/KCT0000694
KCT0000694招募中未知

Early Administration of Intravenous Tranexamic Acid forUpper Gastrointestinal Bleeding Prior to Endoscopy

Seoul National University Bundang Hospital0 个研究点目标入组 414 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
414

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Chief complaint of hematemesis, melena or hematochezia
  • 2. and objective signs of upper gastrointestinal bleeding

排除标准

  • 1. Pregnant woman, age less than 18
  • 2. Patients whose use of the study drug is contraindicated
  • i) Increased thromboembolic risk
  • a. History of thromboembolic disease
  • b. Alleged inherited thrombophilic disorders
  • c. Malignancy (except those cured and has not recurred more than two years)
  • d. Nephrotic syndrome
  • e. Estrogen use
  • f. Pregnancy
  • g. HIT, APA
  • ii)High-risk for cardioembolism
  • a. Underlying structural heart disease where anticoagulation is indicated
  • b. Underlying cardiac rhythm disorder where anticoagulation is indicated (e.g. atrial fibrillation/flutter)
  • iii) Possibilities of ongoing DIC
  • a. Signs and symptoms suggestive of clinically significant infectious disease (e.g. body temperature > 38 degree)
  • b. Any malignancy except those cured and has not recurred more than two years
  • iv) Patients with history or presence of subarachnoid hemorrhage
  • v) Acquired color vision impairment, visual loss and retinal venous and arterial occlusions
  • vi) Past history of seizure or organic brain lesion that predispose to seizure disorder
  • 3. Previous history of variceal bleeding
  • 4. Cases where informed consent is unobtainable

研究者

相似试验

招募中
4 期
Tranexamic Acid for severe endometriosis surgeryReproductive Health and Childbirth - Other reproductive health and childbirth disordersEndometriosis
ACTRN12618001318279The Royal Women's Hospital200
进行中(未招募)
1 期
Peroperative Administration of Tranexamic acid in gastric bypass to reduce haemorrhage in patients with morbid obesityMorbid obesityMedDRA version: 21.1Level: LLTClassification code: 10068900Term: Bariatric surgery Class: 10042613MedDRA version: 21.0Level: LLTClassification code: 10027966Term: Morbid obesity Class: 10027433MedDRA version: 21.1Level: LLTClassification code: 10059610Term: Obesity surgery Class: 10042613
CTIS2024-513570-22-00Sint Franciscus Vlietland Groep Stichting1,524
招募中
3 期
Peroperative Administration of Tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce hemorrhage rates (PATRY study): a randomized controlled trial
NL-OMON53532Franciscus Ziekenhuis1,524
招募中
4 期
Efficacy and Safety of Intravenous Tranexamic Acid on Perioperative Blood Loss in Spinal Metastasis Decompressive Surgery: A Double-blinded, Randomized, Placebo-controlled TrialSpinal metastasis occurs in approximately 15.67% of all cancer cases, with 1 in 10 of these patients experiencing nerve compression. This compression leads to sensory loss, muscle weakness, and loss of bowel and bladder control, significantly impacting patients&#039
TCTR20240608003Department Orthopaedic Surgery, Mahidol University Faculty of Medicine Siriraj Hospital108
已完成
1 期
Effect of prophylactic intravenous tranexamic acid on blood loss after cesarean deliverypostpartum blood loss.
IRCT20091010002558N7Ghoum University of Medical Sciences44
Tranexamic Acid for Upper Gastrointestinal Bleeding | 临床试验